New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2013
07:45 EDTMRData suggests Mindray Medical poised to report strong Q1, says Oppenheimer
Oppenheimer believes that accelerating medical device exports as shown by ShenZhen customs data and overall Chinese export data suggests that Mindray Medical is poised to report strong Q1 results. The firm maintains an Outperform rating on the stock.
News For MR From The Last 14 Days
Check below for free stories on MR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 11, 2014
13:14 EDTMRMindray Medical downgraded earlier to Equal Weight at Morgan Stanley
Morgan Stanley downgraded Mindray Medical earlier due to continued operating deleveraging. Target to $37 from $44.
April 7, 2014
10:18 EDTMRFollow-up: Mindray Medical downgraded at Goldman
Subscribe for More Information
10:15 EDTMRMindray Medical downgraded to Neutral from Buy at Goldman
Price target lowered to $31.20 from $45.50.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use